AMSTERDAM and VIENNA, Austria, Sept.
18, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX:
PHIA), a global leader in health technology, today announced new
OB/GYN innovations, aBiometry AssistA.I, TouchVue and
Tilt[1], as well as the eL18-4 transducer[2] available on Philips
EPIQ 7 and 5 and Affiniti 70 ultrasound systems. Showcased at the
27th World Congress on Ultrasound in Obstetrics and Gynecology
(ISUOG), Philips' OB/GYN ultrasound solutions are designed to give
clinicians more information earlier in pregnancy, making it easier
to provide a confident diagnosis and overcome diagnostic
challenges. They feature innovations such as anatomical
intelligence, fingertip control and enhanced imaging versatility.
Philips will also debut its new InnoSight touch-screen based
diagnostic compact ultrasound, which offers exceptional image
quality and performance.
"At Philips, we are committed to meeting the unique and growing
needs of OB/GYNs and their patients through innovation," said
Vitor Rocha, Ultrasound Business
Leader at Philips. "Deeper levels of definition and clarity enable
clinicians to make early, evidence-based decisions, and our
solutions with ergonomic tools help to further optimize workflow to
provide clinicians more time with patients. Our ultrasound
solutions are designed for life, giving clinicians diagnostic
confidence and their patients peace of mind."
Solutions Today and Tomorrow
Philips will
showcase its wide portfolio of OB/GYN ultrasound tools at ISUOG
2017, including the newly debuted:
- aBiometry AssistA.I., with its anatomical
intelligence of fetal anatomy that preplaces measurement cursors on
selected structures, it reduces conventional measurement steps to
streamline fetal measurement and reporting workflow.
- TrueVue with TouchVue interface, utilizes the EPIQ touch
panel allowing users to intuitively interact and direct both the
volume rotation and internal light source, creating photorealistic
3D fetal images that allow deeper connection between the fetus and
future parents.
- Tilt maximizes OB/GYN imaging versatility with a new 2D
Tilt feature of the 3D9-v3 transducer allowing for lateral scanning
of anatomical structures that are off-axis without having to
manually angle the transducer to provide more comfort to the
patient.
- The eL18-4 transducer features a multi-row array
configuration for full electronic focusing of the elevation plan to
provide imaging with exceptional detail resolution and tissue
uniformity for clinical solutions including obstetrics.
- The new InnoSight diagnostic compact ultrasound system
features an ergonomic, intuitive design and clinical versatility to
meet the mobility needs across a wide range of applications.
These innovative features complement the existing suite of
OB/GYN ultrasound visualization tools from Philips, which will also
be on display: GlassVue transparent 3D visualization, with
its internal light source, which provides an early, more
transparent view of the fetal anatomy, aRevealA.I.
Ultrasound (AIUS) 3D fetal face algorithm that automatically
removes extraneous information to quickly and easily reveal the 3D
fetal face, and MaxVue, which allows clinicians to
experience ultrasound imaging in 16:9 Full High Definition
(FHD).
"Philips' latest OB/GYN ultrasound offerings provide clinicians
with the tools to deliver diagnostic confidence needed to deliver
the best care for patients," said Dr. Michael Ruma, maternal-fetal medicine specialist
at Perinatal Associates of New
Mexico. "The beginning of a new life is a special time, and
Philips' solutions allow clinicians to focus on the needs of each
expecting mother."
For more information on Philips' OB/GYN ultrasound offerings,
including, aBiometry AssistA.I, TouchVue and Tilt, visit
http://philips.to/2qpPd7F. Stop by the Philips booth (#2) at ISUOG
2017, in Vienna, Austria, from
September 16-19, to experience its
latest advancements in OB/GYN ultrasound, and follow
@PhilipsLiveFrom http://www.philips.com/ecr for updates
throughout the congress.
[1] aBiometry AssistA.I, TouchVue and Tilt are 510(k)
pending and not yet available in the USA
[2] The eL18-4 transducer is 510(k) pending and not yet available
in the USA
For further information, please contact:
Alicia Cafardi
Philips Group Press Office
Mobile: +1 412 523 9616
Email: Alicia.Cafardi@philips.com
Twitter: @aliciacafardi
Sarah Haeger
Philips Ultrasound
Mobile: +1 206-920-8726
Email: Sarah.Haeger@philips.com
Twitter: @sarahhaeger
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and
health informatics, as well as in consumer health and home care.
Philips' health technology portfolio generated 2016 sales of
EUR 17.4 billion and employs
approximately 71,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
View original content with
multimedia:http://www.prnewswire.com/news-releases/philips-introduces-new-obgyn-ultrasound-innovations-at-isuog-2017-300520969.html
SOURCE Royal Philips